| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Sierra Miles offers the next level of IT Support. Let us take care of your network to allow you to get back to what matters, your business.
SearchAmerica, Inc is a Osseo, MN-based company in the Software & Internet sector.
US Networkx is a Jackson, MS-based company in the Software and Internet sector.
Denim Health is a company that uses conversational AI to help patients access the right physicians, schedule appointments, and navigate the health system.